Latest Going Concern News

Page 10 of 95
Matsa Resources has received the final A$45 million payment from AngloGold Ashanti for five Lake Carey tenements, completing the transaction. Total payments under the agreement reached A$70.125 million including GST, while AngloGold retains a right of first refusal over Fortitude North until September 2027.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Panorama Auto Trust 2023-1 reported a $9.3 million profit attributable to its unitholder for the year ended 30 June 2026, but says it expects to wind up and liquidate within 12 months. The accounts were prepared on a liquidation basis, with PwC issuing an unmodified audit opinion alongside an emphasis of matter on the planned termination.
Claire Turing
Claire Turing
20 Oct 2026
Aeris Environmental has secured $1.5 million from two sophisticated investors to accelerate its Syncromesh building intelligence platform, while issuing a further 2.05 million shares for advisory services. The capital arrives as the company seeks to turn its smart-building technology pipeline into recurring revenue.
Victor Sage
Victor Sage
20 Oct 2026
International Equities Corporation has returned to a modest annual profit after exiting serviced apartments, but the recovery is fragile. Cash fell sharply, operating cash flow remained negative and the auditor highlighted material uncertainty over the group’s ability to continue as a going concern.
Eva Park
Eva Park
19 Oct 2026
Sunshine Metals is moving Mt Moss toward a planned mid-2027 first gold pour, but its annual report carries a material uncertainty over going concern as the company faces a $10 million deferred payment and roughly $30 million of development spending. The ASX-listed explorer reported a narrower FY2026 loss and $20.57 million in cash after a year of major capital raisings and project expansion.
Maxwell Dee
Maxwell Dee
19 Oct 2026
White Cliff Minerals shareholders have approved an A$8.77 million placement to Hancock Prospecting, giving the private company an expected 13.5% stake and funding a faster exploration campaign at Rae. The capital is aimed at advancing Danvers 1 towards a maiden resource while testing a much larger copper system across Nunavut.
Maxwell Dee
Maxwell Dee
19 Oct 2026
IODM has posted its strongest-ever September revenue as new university contributions accelerate across the UK and Europe, while its cash position leaves little room for execution missteps. The company ended the quarter with A$747,000 in cash and an estimated 1.2 quarters of funding.
Sophie Babbage
Sophie Babbage
19 Oct 2026
Matsa Resources has flagged material uncertainty over its ability to continue as a going concern after a $39.4 million FY2026 loss, negative net assets and a dispute that halted Devon mining. A pending $55 million AngloGold transaction could provide substantial liquidity, but most of the cash remains tied to completion and debt repayment.
Maxwell Dee
Maxwell Dee
16 Oct 2026
Bounty Oil & Gas reported a larger FY2026 loss and weaker production, while reshaping its portfolio around Queensland oil development and a proposed deepwater Liberia entry. The strategy is backed by fresh equity, but depends on further funding, regulatory progress and a production sharing contract that has not yet been finalised.
Victor Sage
Victor Sage
16 Oct 2026
Neometals has cut its annual loss and sharpened its portfolio, but Deloitte has warned of a material uncertainty over the company’s ability to continue as a going concern. The miner says it may need about A$5 million in additional funding from December while pursuing unpaid placement proceeds from Omaha Value Holdings.
Victor Sage
Victor Sage
16 Oct 2026
Noxopharm has completed its first-in-human safety trial for SOF-SKN and advanced the wider Sofra platform, but its annual report flags a material uncertainty over funding. The biotech ended June with A$293,573 in cash, net liabilities of A$3.65 million and a need for additional capital.
Ada Torres
Ada Torres
16 Oct 2026
Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.
Ada Torres
Ada Torres
16 Oct 2026

Browse the archive

Full archive